Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Pancreatic cancer: Where are we now and where are we going?

New targets on the horizon: Integrating genomics with tumour microenvironment

Date

28 Sep 2019

Session

Pancreatic cancer: Where are we now and where are we going?

Topics

Cytotoxic Therapy

Tumour Site

Pancreatic Adenocarcinoma

Presenters

Eileen O'Reilly

Authors

E.M. O'Reilly

Author affiliations

Medicine, Memorial Sloan-Kettering Cancer Center, 10065 - New York/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

28 Sep 2019

Molecular profiling of pancreatic cancer in guiding tumour biology understanding and drug target discovery

Presenter: David Tuveson

Session: Pancreatic cancer: Where are we now and where are we going?

Resources:

Slides

Webcast

28 Sep 2019

Can we be more precise in peri-operative therapy?

Presenter: Michel Ducreux

Session: Pancreatic cancer: Where are we now and where are we going?

Resources:

Slides

Webcast

28 Sep 2019

Locally advanced disease: Drugs alone or with the addition of radiotherapy?

Presenter: Stefano Cascinu

Session: Pancreatic cancer: Where are we now and where are we going?

Resources:

Slides

Webcast